xmlns:atom="http://www.w3.org/2005/Atom" xmlns:atom="http://www.w3.org/2005/Atom"
Textual Amendments
F1Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1
28A.—(1) An NHS pharmacist must ensure that at pharmacy premises, other than distance selling premises, there is a consultation room which is—
(a)clearly designated as a room for confidential conversations;
(b)distinct from the general public areas of the pharmacy premises; and
(c)a room where both a person accessing pharmaceutical services and a person performing pharmaceutical services are able to be seated together and communicate confidentially.
(2) Where, in the opinion of [F1NHS England], pharmacy premises other than distance selling premises included on a pharmaceutical list on the relevant day are too small for a consultation room—
(a)the NHS pharmacist in respect of those premises may, with the agreement of [F1NHS England], comply with paragraph 28B instead of sub-paragraph (1); and
(b)for these purposes, references to distance selling premises in paragraph 28B are to be treated as a reference to the premises about which [F1NHS England] has formed the opinion that they are too small for a consulting room.
(3) An NHS pharmacist in respect of premises that were on a pharmaceutical list on the relevant day but no advanced services were provided at or from those premises during the year before the relevant day need not comply with sub-paragraphs (1) or (2) in respect of those premises before 1st April 2023.
(4) In this paragraph, “the relevant day” means the day of the coming into force of regulation 15(1) of the National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2020.]
Textual Amendments